Skip to main content
SpringerLink
Log in

Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor

  • Hepatobiliary Tumors
  • Published:
Annals of Surgical Oncology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Dee EC, Freret ME, Horick N, et al. Patterns of failure and the need for biliary intervention in resected biliary tract cancers after chemoradiation. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08967-9.

    Article  PubMed  Google Scholar 

  2. Dee EC, Freret ME, Wo JY. ASO author reflections: Adjuvant chemoradiation for patients with resected biliary tract cancers. Ann Surg Oncol. 2020. https://doi.org/10.1245/s10434-020-08970-0.

    Article  PubMed  Google Scholar 

  3. Ma W-J, Jin Y-W, Wu Z-R, et al. Meta-analysis of randomized clinical trials of adjuvant chemotherapy for resected biliary tract cancers. HPB. 2020;22:939–49.

    Article  Google Scholar 

  4. Ebata T, Hirano S, Konishi M, et al. Randomized clinical trial of adjuvant gemcitabine chemotherapy versus observation in resected bile duct cancer. Br J Surg. 2018;105:192–202. https://doi.org/10.1002/bjs.10776.

    Article  CAS  PubMed  Google Scholar 

  5. Edeline J, Benabdelghani M, Bertaut A, et al. Gemcitabine and oxaliplatin chemotherapy or surveillance in resected biliary tract cancer (Prodige 12-accord 18-Unicancer GI): a randomized phase III study. J Clin Oncol. 2019. https://doi.org/10.1200/jco.18.00050.

    Article  PubMed  Google Scholar 

  6. Primrose JN, Fox RP, Palmer DH, et al. Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study. Lancet Oncol. 2019. https://doi.org/10.1016/s1470-2045(18)30915-x.

    Article  PubMed  Google Scholar 

  7. Takada T, Amano H, Yasuda H, et al. Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer. 2002;95:1685–95. https://doi.org/10.1002/cncr.10831.

    Article  PubMed  Google Scholar 

  8. Neoptolemos JP, Moore MJ, Cox TF, et al. Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. JAMA. 2012;308:147–56. https://doi.org/10.1001/jama.2012.7352.

    Article  CAS  PubMed  Google Scholar 

  9. Ben-Josef E, Guthrie KA, El-Khoueiry AB, et al. SWOG S0809: a phase II intergroup trial of adjuvant capecitabine and gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma. J Clin Oncol. 2015;33:2617–22. https://doi.org/10.1200/jco.2014.60.2219.

    Article  CAS  PubMed  Google Scholar 

  10. Horgan AM, Amir E, Walter T, Knox JJ. Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol. 2012;30:1934–40. https://doi.org/10.1200/jco.2011.40.5381.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Harvard Medical School, Boston, MA, USA

    Edward Christopher Dee BS & Jennifer Y. Wo MD

  2. Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA

    Morgan E. Freret MD, PhD

  3. Department of Radiation Oncology, Massachusetts General Hospital, Harvard Medical School, Boston, MA, USA

    Jennifer Y. Wo MD

Authors
  1. Edward Christopher Dee BS
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Morgan E. Freret MD, PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Jennifer Y. Wo MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Jennifer Y. Wo MD.

Ethics declarations

Disclosure

The authors declare that they have no conflict of interest.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Dee, E.C., Freret, M.E. & Wo, J.Y. Chemoradiation for Patients with Resected Biliary Tract Cancers in the Adjuvant Setting: Reply to a Letter to the Editor. Ann Surg Oncol 27 (Suppl 3), 937–939 (2020). https://doi.org/10.1245/s10434-020-09130-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1245/s10434-020-09130-0

Search

Navigation